{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:23:43Z","timestamp":1763058223648,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.immuni.2019.01.016","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T10:44:09Z","timestamp":1550573049000},"page":"280-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Live or Let Die: T Cell Survival in Cancer Immunotherapy"],"prefix":"10.1016","volume":"50","author":[{"given":"Janne","family":"Ruotsalainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"T\u00fcting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2019.01.016_bib1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nm1554","article-title":"IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy","volume":"13","author":"Berner","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.01.016_bib2","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.01.016_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.immuni.2017.09.012","article-title":"Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy","volume":"47","author":"Glodde","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.01.016_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.01.016_bib5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.172.6.1735","article-title":"Interferon gamma plays a critical role in induced cell death of effector T\u00a0cell: a possible third mechanism of self-tolerance","volume":"172","author":"Liu","year":"1990","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.01.016_bib6","article-title":"Cancer immunoediting and resistance to T\u00a0cell-based immunotherapy","author":"O\u2019Donnell","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.immuni.2019.01.016_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2019.01.006","article-title":"Clonal deletion of tumor-specific T\u00a0cells by interferon-\u03b3 confers therapeutic resistance to combination immune checkpoint blockade","volume":"50","author":"Pai","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.01.016_bib8","doi-asserted-by":"crossref","first-page":"12510","DOI":"10.1128\/JVI.01776-13","article-title":"Gamma interferon regulates contraction of the influenza virus-specific CD8 T\u00a0cell response and limits the size of the memory population","volume":"87","author":"Prabhu","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.01.016_bib9","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41591-018-0250-0","article-title":"Is earlier better for melanoma checkpoint blockade?","volume":"24","author":"Robert","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.01.016_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T\u00a0cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761319300391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761319300391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:03:58Z","timestamp":1761033838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761319300391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1074761319300391"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2019.01.016","relation":{},"ISSN":["1074-7613"],"issn-type":[{"type":"print","value":"1074-7613"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live or Let Die: T Cell Survival in Cancer Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2019.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2019.01.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}